why choose us

First received: March 10, 2023

Clinical Trial: A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants With Type 1 Diabetes

Study Status: Completed

Recruit Status: RECRUITING

Condition: Type 1 Diabetes

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Placebo and Comparator-Controlled Crossover Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants With Type 1 Diabetes

Brief Summary: This study will be conducted primarily to evaluate the effects of CT-868 on glucose homeostasis in participants with Type 1 Diabetes Mellitus.

Read more